Amantadine: A new treatment for refractory electrical status epilepticus in sleep
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 84, 74-78
Abstract
No abstract availableKeywords
Funding Information
- Elsie and Isaac Fogelman Endowment
- Hughes Family Foundation
- UCLA Children's Discovery and Innovation Institute
This publication has 27 references indexed in Scilit:
- GRIN2A mutations cause epilepsy-aphasia spectrum disordersNature Genetics, 2013
- GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunctionNature Genetics, 2013
- Epileptic encephalopathies of the Landau‐Kleffner and continuous spike and waves during slow‐wave sleep types: Genomic dissection makes the link with autismEpilepsia, 2012
- Early thalamic lesions in patients with sleep-potentiated epileptiform activityNeurology, 2012
- Amantadine for the Treatment of Refractory Absence Seizures in ChildrenPediatric Neurology, 2012
- CSWS‐related autistic regression versus autistic regression without CSWSEpilepsia, 2009
- EPILEPSY SURGERY IN CHILDREN WITH ELECTRICAL STATUS EPILEPTICUS IN SLEEPNeurosurgery, 2009
- Early Thalamic Injury Associated with Epilepsy and Continuous Spike–Wave during Slow SleepEpilepsia, 2005
- Landau–Kleffner syndrome, electrical status epilepticus in slow wave sleep, and language regression in childrenMental Retardation and Developmental Disabilities Research Reviews, 2004
- Effect of add-on amantadine therapy for refractory absence epilepsyThe Journal of Pediatrics, 1992